Skip to main content
Equibles

EPRX · Eupraxia Pharmaceuticals Inc. · Investor Relations

Use EPRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EPRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
9.2300 CAD -0.2500 (-2.64%) At close · Nov 5 Intraday price with Plus
Rebalance outlook locked

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-10 21:40 UTC Stifel 2026 Healthcare Conference Conference
2026-11-13 13:30 UTC Virtual Analyst Day to Discuss EP-104GI for Eosinophilic Esophagitis Presentation
2026-11-16 13:30 UTC 2026 Jefferies Global Healthcare Conference in London Conference

Past events

Date Event Type
2026-10-22 Craig Hallum Biotech Catalyst Virtual Conference Conference
2026-09-16 Morgan Stanley 24th Annual Global Healthcare Conference Conference
2026-09-14 H.C. Wainwright 28th Annual Global Investment Conference Conference
2026-09-11 Cantor Global Healthcare Conference Conference
2026-07-30 Virtual KOL Event to Discuss Upper Endoscopies and EoE Patients - Understanding How EP-104GI Administration Fits Within Clinical Practice Event
2026-06-03 Jefferies Global Healthcare Conference Conference
2026-05-04 Virtual Investor Event at Digestive Disease Week 2026 Event
2026-04-21 2026 Bloom Burton & Co. Healthcare Investor Conference Conference
2026-04-14 Raymond James Biotech Innovation Symposium Event
2025-10-01 Webinar - Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs Webcast
2025-09-09 H.C. Wainwright 27th Annual Global Investment Conference Conference
2025-09-05 Cantor Global Healthcare Conference Conference
2025-08-13 Canaccord 45th Annual Growth Conference Conference
2025-05-14 Tribe Public Webinar Presentation and Q&A Event titled, “Hard To Swallow: An Underdiagnosed Condition Rising To Surface (EOE) Presentation
2025-05-13 Radius Research - Investments is hosting Eupraxia Pharmaceuticals with CEO James Helliwell for a Live Webinar and Q&A Event

Source: https://www.eupraxiapharma.com/investors/